Observe Medical ASA – Primary insider notice
Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue").
Navamedic ASA ("NAVA"), represented at the Company's board of directors by Kathrine Gamborg Andreassen, has today, on 6 July 2020, received notice of its allocation of 1,022,727 Offer Shares in the Rights Issue.
Following allocation of the Offer shares, NAVA, with its related parties, owns 4,222,727 shares in the Company, which corresponds to a shareholding of 21.73% in the company.
This information is subject to disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.